Analyst firms · Citigroup · LLY
Citigroup LLY price target and rating history
Eli Lilly and Company (LLY) · Health Care
Citigroup rates Eli Lilly and Company (LLY) Buy with a $1,060 price target, as of its latest action on Sep 13, 2024. It has published 3 rating actions on LLY since September 2021, including 1 upgrade and 0 downgrades. Across 10 firms with a LLY price target in the last 12 months, the median target is $1,240.
- Current rating
- Buy
- Price target
- $1,060
- Median target, all firms
- $1,240
- Actions on LLY
- 3
Citigroup price target on LLY
Every Citigroup rating on LLY
- Sep 13, 2024
- Jul 26, 2023
- Sep 29, 2021
How other firms rate LLY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Berenberg | Buy | $1,400 | Sep 15, 2026 |
| HSBC | Reduce | $850 | Mar 17, 2026 |
| RBC Capital Markets | Outperform | $1,250 | Feb 25, 2026 |
| Barclays | Overweight | $1,350 | Feb 20, 2026 |
| UBS | Buy | $1,250 | Jan 7, 2026 |
| Daiwa | Buy | $1,230 | Dec 16, 2025 |
| Goldman Sachs | Buy | $1,145 | Dec 15, 2025 |
| BofA Securities | Buy | $1,268 | Dec 15, 2025 |
| Scotiabank | Sector Outperform | $1,165 | Nov 13, 2025 |
| Leerink Partners | Outperform | $1,104 | Nov 10, 2025 |
Questions about Citigroup and LLY
- What is Citigroup's price target for LLY?
- Citigroup's latest stated price target for Eli Lilly and Company (LLY) is $1,060, from its action on Sep 13, 2024.
- What is Citigroup's rating on LLY?
- Citigroup rates LLY Buy, a bullish rating, as of Sep 13, 2024.
- When did Citigroup last change its view on LLY?
- On Sep 13, 2024, Citigroup resumes coverage at Buy, price target $1,060.
- How does Citigroup's LLY target compare with other analysts?
- Across 10 firms with a LLY price target in the last 12 months, the median target is $1,240.
More LLY rating histories
- Berenberg4
- HSBC4
- Barclays3
- UBS4
- Daiwa4
- BofA Securities4
- Leerink Partners3
- BMO Capital Markets3
- DZ Bank3
- Morgan Stanley6
- Wells Fargo3
All Citigroup ratingsLLY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.